Cherry Tree Wealth Management, LLC Amphastar Pharmaceuticals, Inc. Transaction History
Cherry Tree Wealth Management, LLC
- $415 Billion
- Q1 2025
A detailed history of Cherry Tree Wealth Management, LLC transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Cherry Tree Wealth Management, LLC holds 58 shares of AMPH stock, worth $1,456. This represents 0.0% of its overall portfolio holdings.
Number of Shares
58Holding current value
$1,456% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding AMPH
# of Institutions
262Shares Held
34.4MCall Options Held
26.5KPut Options Held
7.9K-
Black Rock Inc. New York, NY5.94MShares$149 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.71MShares$68.2 Million0.0% of portfolio
-
Td Asset Management Inc2.21MShares$55.6 Million0.06% of portfolio
-
State Street Corp Boston, MA1.6MShares$40.1 Million0.0% of portfolio
-
Neuberger Berman Group LLC New York, NY1.37MShares$34.5 Million0.04% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $1.23B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...